The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 15, 2020

Filed:

Nov. 04, 2013
Applicants:

The Johns Hopkins University, Baltimore, MD (US);

University of Maryland, Baltimore, MD (US);

Inventors:

Zachary Kaminsky, Baltimore, MD (US);

Jennifer L. Payne, Baltimore, MD (US);

Todd Gould, Baltimore, MD (US);

Assignees:

THE JOHNS HOPKINS UNIVERSITY, Baltimore, MD (US);

UNIVERSITY OF MARYLAND, BALTIMORE, Baltimore, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6883 (2018.01); G16H 50/30 (2018.01); G01N 15/10 (2006.01); G01N 15/00 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6883 (2013.01); G01N 15/10 (2013.01); G16H 50/30 (2018.01); C12Q 2600/118 (2013.01); C12Q 2600/154 (2013.01); C12Q 2600/158 (2013.01); C12Q 2600/16 (2013.01); G01N 2015/008 (2013.01); G01N 2015/1062 (2013.01);
Abstract

The present invention relates to the field of post-partum depression. More specifically, the present invention relates to the use of biomarkers to diagnose post-partum depression or predict a risk thereof. In a specific embodiment, a method for identifying a likelihood of PPD in a patient comprises the steps of (a) providing a sample from the patient; (b) measuring white blood cell type counts and DNA methylation levels of a panel of biomarkers in the sample collected from the patient, wherein the panel of biomarkers comprises HP1BP3 and TTC9B and the white blood cell type counts comprise monocytes and non-monocytes; and (c) identifying the patient as likely to develop PPD based on the relative DNA methylation levels at the biomarker loci relative to the ratio of monocytes:non-monocytes.


Find Patent Forward Citations

Loading…